Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Immune Intervention Reduces β-Cell Death in Type 1 Diabetes
Improvement in C-peptide responses seen with teplizumab; associated with decreased β-cell death
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

September 14, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Highly Sensitive Troponin Test IDs Asymptomatic Heart Damage

New Role of Patient As Consumer Requires Market Changes

Review: ASA to Prevent Primary CVD Should Be Individualized

Glycemic Control Linked to Lumbar Surgery Complications

AHA: Inflammation May Explain Vascular Damage in Diabetes

FDA Approves Novel Weight-Loss Medication